Risk of HBV reactivation in patients with B-cell lymphomas...

  • Main
  • 2018 / 10
  • Risk of HBV reactivation in patients with B-cell lymphomas...

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy

Kusumoto, Shigeru, Arcaini, Luca, Hong, Xiaonan, Jin, Jie, Kim, Won Seog, Kwong, Yok Lam, Peters, Marion G., Tanaka, Yasuhito, Zelenetz, Andrew D., Kuriki, Hiroshi, Fingerle-Rowson, Günter, Nielsen, T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2018-04-848044
Date:
October, 2018
File:
PDF, 440 KB
english, 2018
Conversion to is in progress
Conversion to is failed